PNC Financial Services Group’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-3,691	Closed	-$396K	–	4871
2023 Q1	$396K	Buy	3,691 +2,269	+160%	+$244K	﹤0.01%	1694
2022 Q4	$156K	Buy	1,422 +1,220	+604%	+$134K	﹤0.01%	2288
2022 Q3	$12K	Buy	202 +104	+106%	+$6.18K	﹤0.01%	3695
2022 Q2	$3K	Buy	+98	New	+$3K	﹤0.01%	4149